Oxford Square Capital (NASDAQ:OXSQ) Downgraded by Wall Street Zen to "Strong Sell"

Key Points

• Oxford Square Capital was downgraded by Wall Street Zen from “hold” to “strong sell”, while Weiss Ratings also reiterated a sell rating. MarketBeat says the overall analyst sentiment on the stock is now “Sell.”
• The stock was down 2.2% and opened at $1.82, near its 50-day and 200-day moving averages. It remains close to its 1-year low of $1.56 and below its 1-year high of $2.50.
• The company’s latest quarterly results missed expectations, posting EPS of $0.05 versus a $0.06 estimate and revenue of -$23.52 million versus an expected $9.84 million. Despite the weak results, hedge funds and other institutional investors own 6.44% of the stock.

Oxford Square Capital (NASDAQ:OXSQ - Get Free Report) was downgraded by analysts at Wall Street Zen from a "hold" rating to a "strong sell" rating in a report issued on Saturday.

Separately, Weiss Ratings reiterated a "sell (d+)" rating on shares of Oxford Square Capital in a report on Tuesday, April 21st. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has an average rating of "Sell".

Oxford Square Capital Trading Down 2.2%

Oxford Square Capital stock opened at $1.82 on Friday. Oxford Square Capital has a 1-year low of $1.56 and a 1-year high of $2.50. The firm has a market capitalization of $170.22 million, a price-to-earnings ratio of -4.23 and a beta of 0.48. The firm's fifty day moving average price is $1.81 and its two-hundred day moving average price is $1.83.

Oxford Square Capital (NASDAQ:OXSQ - Get Free Report) last released its quarterly earnings data on Wednesday, April 29th. The company reported $0.05 earnings per share for the quarter, missing analysts' consensus estimates of $0.06 by ($0.01). Oxford Square Capital had a negative net margin of 92.37% and a positive return on equity of 14.11%. The business had revenue of ($23.52) million during the quarter, compared to the consensus estimate of $9.84 million.

Hedge Funds Weigh In On Oxford Square Capital

Several large investors have recently modified their holdings of OXSQ. Silverberg Bernstein Capital Management LLC boosted its position in shares of Oxford Square Capital by 42.6% in the first quarter. Silverberg Bernstein Capital Management LLC now owns 106,710 shares of the company's stock valued at $189,000 after acquiring an additional 31,865 shares during the period. StoneX Group Inc. bought a new stake in Oxford Square Capital during the fourth quarter valued at approximately $29,000. McIlrath & Eck LLC bought a new stake in Oxford Square Capital during the fourth quarter valued at approximately $43,000. Alpine Global Management LLC bought a new stake in Oxford Square Capital during the third quarter valued at approximately $42,000. Finally, CANADA LIFE ASSURANCE Co lifted its position in Oxford Square Capital by 72.3% during the third quarter. CANADA LIFE ASSURANCE Co now owns 97,936 shares of the company's stock valued at $155,000 after purchasing an additional 41,105 shares during the last quarter. Hedge funds and other institutional investors own 6.44% of the company's stock.

About Oxford Square Capital

Oxford Square Capital Corp. NASDAQ: OXSQ is a publicly traded business development company that provides flexible financing solutions to U.S. middle-market companies. Chartered as a closed-end management investment company, Oxford Square Capital seeks to generate current income and capital appreciation by investing primarily in secured loans, mezzanine debt and equity co-investments. The firm targets businesses with established cash flows, offering tailored capital structures designed to support growth, recapitalizations and acquisitions.

The company's investment strategy focuses on senior secured first-lien and second-lien loans, subordinated debt and preferred and common equity stakes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.